About Marrone Bio Innovations (NASDAQ:MBII)
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
Industry, Sector and Symbol:
Capitalization:- Market Cap: $29.88 million
- Outstanding Shares: 31,351,000
Average Prices:- 50 Day Moving Avg: $1.11
- 200 Day Moving Avg: $1.26
- 52 Week Range: $0.85 - $2.79
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -2.06
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $16.95 million
- Price / Sales: 1.79
- Book Value: ($1.14) per share
- Price / Book: -0.85
Profitability:- EBITDA: ($21,120,000.00)
- Net Margins: -177.10%
- Return on Assets: -64.21%
Debt:- Debt-to-Equity Ratio: -1.63%
- Current Ratio: 1.37%
- Quick Ratio: 0.98%
Misc:- Average Volume: 102,911 shs.
- Beta: 0.29
- Short Ratio: 17.79
Frequently Asked Questions for Marrone Bio Innovations (NASDAQ:MBII)
What is Marrone Bio Innovations' stock symbol?
Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."
How were Marrone Bio Innovations' earnings last quarter?
Marrone Bio Innovations, Inc. (NASDAQ:MBII) posted its quarterly earnings results on Monday, August, 14th. The company reported ($0.25) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.04. The company earned $6.48 million during the quarter, compared to analysts' expectations of $6.62 million. View Marrone Bio Innovations' Earnings History.
Where is Marrone Bio Innovations' stock going? Where will Marrone Bio Innovations' stock price be in 2017?
3 equities research analysts have issued 12-month target prices for Marrone Bio Innovations' stock. Their predictions range from $1.00 to $4.00. On average, they anticipate Marrone Bio Innovations' stock price to reach $2.50 in the next twelve months. View Analyst Ratings for Marrone Bio Innovations.
Who are some of Marrone Bio Innovations' key competitors?
Some companies that are related to Marrone Bio Innovations include Rambler Metals and Mining PLC (RMM), McCoy Global (MCB), Wolf Minerals Limited (WLFE), Capital Drilling Ltd (CAPD), Obtala Ltd (OBT), Horizonte Minerals Plc (HZM), Amur Minerals (AMC), TransAtlantic Petroleum Ltd (TNP), Canadian Zinc Corp. (CZN), Caledonia Mining Corporation Plc Com (CMCL), Jubilee Platinum PLC (JLP), Trans-Siberian Gold plc (TSG), Beowulf Mining plc (BEM), Banro (BAA), Golden Minerals Co (AUMN), Anglo Asian Mining Plc (AAZ), General Moly (GMO) and Golden Queen Mining (GQM).
Who are Marrone Bio Innovations' key executives?
Marrone Bio Innovations' management team includes the folowing people:
- Timothy T. Fogarty, Independent Chairman of the Board
- James B. Boyd, President, Chief Financial Officer
- Pamela G. Marrone Ph.D., Chief Executive Officer, Director
- Linda V. Moore, Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
- Brian R. Ahrens, Vice President of Sales
- Nancy Hood, Vice President - Marketing
- Timothy B. Johnson Ph.D., Vice President - Field Development and Technical Services
- Keith J. Pitts, Vice President - Regulatory and Government Affairs
- Amit Vasavada Ph.D., Vice President - Research and Development
- Kathleen A. Merrigan Ph.D., Director
How do I buy Marrone Bio Innovations stock?
Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Marrone Bio Innovations' stock price today?
One share of Marrone Bio Innovations stock can currently be purchased for approximately $0.97.
MarketBeat Community Rating for Marrone Bio Innovations (NASDAQ MBII)MarketBeat's community ratings are surveys of what our community members think about Marrone Bio Innovations and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.33) |
| Consensus Price Target: | $2.50 (157.73% upside) |
Consensus Price Target History for Marrone Bio Innovations (NASDAQ:MBII)
Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/15/2017 | HC Wainwright | Set Price Target | Buy | $4.00 | High |  |
| 7/22/2017 | Piper Jaffray Companies | Set Price Target | Hold | $1.00 | High | |
| 5/2/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $2.50 | Low | |
| 3/16/2016 | Rodman & Renshaw | Initiated Coverage | Buy | $3.50 | N/A | |
| 12/31/2015 | Roth Capital | Reiterated Rating | Buy -> Not Rated | $15.00 | N/A | |
(Data available from 10/20/2015 forward)
Earnings History for Marrone Bio Innovations (NASDAQ:MBII)Earnings History by Quarter for Marrone Bio Innovations (NASDAQ MBII)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/14/2017 | Q2 2017 | ($0.21) | ($0.25) | $6.62 million | $6.48 million | View | N/A | |
| 3/29/2017 | Q4 2016 | ($0.26) | ($0.32) | | $2.69 million | View | N/A | |
| 11/14/2016 | Q316 | ($0.22) | ($0.29) | $4.61 million | $3.63 million | View | N/A | |
| 8/9/2016 | Q216 | ($0.28) | ($0.28) | $4.61 million | $5.00 million | View | N/A | |
| 5/12/2016 | Q116 | ($0.27) | ($0.38) | $3.05 million | $2.70 million | View | Listen | |
| 3/30/2016 | Q215 | ($0.40) | ($0.45) | $1.10 million | $1.90 million | View | Listen | |
| 8/7/2014 | Q2 2014 | ($0.49) | ($0.50) | $7.59 million | $3.63 million | View | N/A | |
| 5/13/2014 | Q114 | ($0.37) | ($0.52) | $4.63 million | $2.80 million | View | N/A | |
| 3/6/2014 | Q4 2013 | ($0.40) | ($0.52) | $5.80 million | $5.97 million | View | N/A | |
| 9/12/2013 | Q2 2013 | ($0.33) | ($2.36) | $4.33 million | $4.50 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Marrone Bio Innovations (NASDAQ:MBII)Current Year EPS Consensus Estimate: $-1.05 EPS
Next Year EPS Consensus Estimate: $-0.47 EPS
Dividend History for Marrone Bio Innovations (NASDAQ:MBII)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Marrone Bio Innovations (NASDAQ:MBII)Insider Ownership Percentage: 7.25%
Institutional Ownership Percentage: 51.06%
Insider Trades by Quarter for Marrone Bio Innovations (NASDAQ:MBII)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 4/25/2017 | Ardsley Advisory Partners | Major Shareholder | Buy | 50,000 | $1.72 | $86,000.00 | |
| 6/15/2016 | Richard E Rominger | Director | Buy | 10,000 | $0.94 | $9,400.00 | |
| 6/13/2016 | James Boyd | CFO | Buy | 10,000 | $0.79 | $7,900.00 | |
| 6/9/2016 | George H Kerckhove | Director | Buy | 2,500 | $0.72 | $1,800.00 | |
| 6/9/2016 | Pamela G Marrone | CEO | Buy | 5,000 | $0.72 | $3,600.00 | |
| 6/9/2016 | Timothy B Johnson | VP | Buy | 10,000 | $0.72 | $7,200.00 | |
| 8/14/2014 | George H Kerckhove | Director | Buy | 400 | $5.90 | $2,360.00 | |
| 8/12/2014 | Pamela G Marrone | CEO | Buy | 1,000 | $5.29 | $5,290.00 | |
| 2/12/2014 | Ventures Pte. Ltd. Syngenta | major shareholder | Sell | 332,027 | $14.72 | $4,887,437.44 | |
| 1/29/2014 | Donald Glidewell | CFO | Sell | 75,495 | $17.00 | $1,283,415.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Marrone Bio Innovations (NASDAQ:MBII)
Latest Headlines for Marrone Bio Innovations (NASDAQ:MBII)
| Source: |
|
| Date | Headline |
|---|
 | BRIEF-Marrone Bio signs exclusive agreement with Kenya Biologics
www.reuters.com - October 19 at 6:09 AM |
 | Marrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics Ltd. for Kenya and Tanzania
finance.yahoo.com - October 19 at 6:09 AM |
 | Comparing Israel Chemicals Shs (ICL) and Marrone Bio Innovations (MBII)
www.americanbankingnews.com - October 15 at 6:26 AM |
| Marrone Bio Innovations (MBII) & Its Peers Critical Analysis
www.americanbankingnews.com - October 11 at 4:24 PM |
| Marrone Bio Innovations, Inc. Receives Positive Results From Brazil Trials
finance.yahoo.com - October 11 at 3:19 PM |
| Head to Head Survey: Marrone Bio Innovations (MBII) and The Competition
www.americanbankingnews.com - October 11 at 2:20 PM |
| All You Need To Know About Marrone Bio Innovations Inc’s (MBII) Risks
finance.yahoo.com - October 6 at 10:16 AM |
 | Marrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th
www.nasdaq.com - September 29 at 6:43 PM |
 | Marrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th - GlobeNewswire (press release)
globenewswire.com - September 29 at 1:42 PM |
| Marrone Bio (MBII), Elephant Vert Ink Distribution Deal
finance.yahoo.com - September 25 at 7:18 PM |
| Marrone Bio Innovations Announces Availability of Venerate XC Bioinsecticide Product in New York
finance.yahoo.com - September 25 at 8:33 AM |
| Marrone Bio Innovations (MBII) vs. Israel Chemicals Shs (ICL) Head-To-Head Contrast
www.americanbankingnews.com - September 24 at 2:48 PM |
| Reviewing Israel Chemicals Shs (ICL) & Marrone Bio Innovations (MBII)
www.americanbankingnews.com - September 19 at 2:48 PM |
| Reviewing Marrone Bio Innovations (MBII) & Its Rivals
www.americanbankingnews.com - September 17 at 6:16 AM |
| Head-To-Head Review: Marrone Bio Innovations (MBII) versus The Competition
www.americanbankingnews.com - September 16 at 2:30 AM |
 | Davis-based Marrone Bio Innovations partners with app developer for pilot program
www.bizjournals.com - September 15 at 6:17 AM |
| Marrone Bio Innovations Debuts Highlight Video from the Great Lakes Restoration Information Fair
finance.yahoo.com - September 15 at 6:17 AM |
 | Marrone Bio Innovations (MBII) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 14 at 7:29 AM |
| AgShift Launches Pilot Project with Marrone Bio Innovations to More Efficiently Assess the Impact of Biological Pesticides on the Quality of Fresh Produce
finance.yahoo.com - September 7 at 1:02 AM |
| Financial Survey: Agrium (AGU) versus Marrone Bio Innovations (MBII)
www.americanbankingnews.com - September 4 at 10:12 PM |
| Marrone Bio Innovations to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 11th
finance.yahoo.com - August 30 at 6:24 AM |
| Short Squeeze Coming In Marrone Bio Innovations?
seekingalpha.com - August 28 at 8:20 PM |
| ETFs with exposure to Marrone Bio Innovations, Inc. : August 25, 2017
finance.yahoo.com - August 26 at 7:00 AM |
| Comparing American Vanguard Corporation (AVD) & Marrone Bio Innovations (MBII)
www.americanbankingnews.com - August 23 at 6:28 AM |
| Comparing Monsanto (MON) & Marrone Bio Innovations (MBII)
www.americanbankingnews.com - August 22 at 4:08 AM |
| Marrone Bio Innovations, Inc. Helps Sponsor Educational Symposia for Growers in Honduras and Chile
finance.yahoo.com - August 21 at 7:49 PM |
| Head-To-Head Contrast: Marrone Bio Innovations (MBII) & Ciner Resources (CINR)
www.americanbankingnews.com - August 21 at 12:22 PM |
| Marrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 17 at 1:58 AM |
| Edited Transcript of MBII earnings conference call or presentation 14-Aug-17 8:30pm GMT
finance.yahoo.com - August 16 at 6:04 AM |
| Marrone Bio Innovations, Inc. (MBII) Given a $4.00 Price Target at HC Wainwright
www.americanbankingnews.com - August 15 at 6:40 PM |
| Marrone Bio Innovations, Inc. (MBII) Releases Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - August 15 at 12:38 PM |
| Marrone Bio Innovations, Inc. Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 15 at 1:20 AM |
| Contrasting Marrone Bio Innovations (NASDAQ:MBII) and American Vanguard Corporation (AVD)
www.americanbankingnews.com - August 7 at 12:10 AM |
| Marrone Bio Innovations, Partner Organizations Celebrate Major Milestone in Testing Invasive Zebra and Quagga Mussel Treatment under Large-Scale Open Water Conditions
finance.yahoo.com - August 3 at 4:19 AM |
| Marrone Bio Innovations to Report Second Quarter 2017 Financial Results and Host a Conference Call on Monday, August 14th at 1:30 p.m. Pacific time
finance.yahoo.com - August 2 at 3:48 AM |
| Marrone Bio Innovations to Present at Investor Conferences in August
finance.yahoo.com - July 27 at 4:12 AM |
| Marrone Bio ships first products to Africa
finance.yahoo.com - July 25 at 3:59 AM |
| Marrone Bio Innovations Expands its Products to Africa
finance.yahoo.com - July 24 at 12:57 PM |
| Marrone Bio Innovations Inc (NASDAQ:MBII) Given a $1.00 Price Target by Piper Jaffray Companies Analysts
www.americanbankingnews.com - July 23 at 10:02 PM |
 | Top Marijuana Stocks on the NASDAQ
www.investopedia.com - July 20 at 6:05 AM |
| Marrone Bio Innovations, Inc. Products Show Impressive Results in International Trials Against Key Pests and Diseases
finance.yahoo.com - July 11 at 1:12 AM |
| ETFs with exposure to Marrone Bio Innovations, Inc. : July 5, 2017
finance.yahoo.com - July 5 at 4:17 PM |
| Marrone Bio Innovations (MBII) Presents At 7th Annual LD Micro Invitational Conference - Slideshow
seekingalpha.com - June 9 at 12:23 AM |
 | Marrone Bio's (MBII) Q1 Loss in Line, Revenues Up Y/Y
www.zacks.com - May 15 at 10:32 AM |
| BRIEF-Marrone Bio Innovations inks deal with Jet Harvest Solutions
www.reuters.com - May 12 at 1:58 AM |
| Marrone Bio Innovations' (MBII) CEO Pam Marrone on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 1:58 AM |
| BRIEF-Marrone Bio Innovations says offering of 5.71 mln common shares priced at $1.40/share
www.reuters.com - April 26 at 6:54 PM |
 | UPDATE: Marrone Bio (MBII) Prices 5.71M Common Stock Offering at $1.40/Share
www.streetinsider.com - April 25 at 5:48 PM |
| Marrone Bio raising $8 million with stock offering
www.bizjournals.com - April 25 at 5:48 PM |
| BRIEF-Marrone Bio Innovations reports proposed public offering of common stock
www.reuters.com - April 24 at 7:16 PM |
Marrone Bio Innovations (MBII) Chart for Friday, October, 20, 2017
